Fact CheckerSign in

NCT03713515CompletedPhase 4

Bridging the Evidence-to-practice Gap

Bridging the Evidence-to-practice Gap: Evaluating Practice Facilitation as a Strategy to Accelerate Translation of a Systems-level Adherence Intervention Into Safety Net Practices

Source: ClinicalTrials.gov · Last updated 10 Jun 2026

Brief summary (registry, in English)

The proposed project will address this evidence-to-practice gap by evaluating the effect of practice facilitation (PF) of the intervention implementation fidelity (primary outcome) and clinical measures at 12 months (secondary outcomes).

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
652 (actual)
First submitted
17 Oct 2018
Start date
1 Dec 2020
Primary completion date
30 May 2024
Lead sponsor
NYU Langone Health
NCT number
NCT03713515

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 652
  • From 1 Dec 2020 to the primary completion date, 30 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Participation in other hypertension-related clinical trials
  • Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR)

Other

  • Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks)
  • Plan to discontinue care at their practice within the next 12 months
    • Clinic and nonclinical staff exclusion criteria:
  • Refuse to participate

Who the study is looking for

  • Self-identify as Latino
  • Be fluent in English or Spanish
  • Be age 18 years or older
  • Receiving care in a safety-net primary care practice
  • Have uncontrolled HTN documented in the electronic health record (EHR) on at least two visits in the past year (defined as an average BP ≥ 140/90 mmHg)
  • Have been prescribed at least one anti-hypertensive medication and be non- adherent to their medications, defined as adherence \<80% in the preceding 12 months, as determined by prescription orders obtained from the clinic EHR.
    • Clinic and nonclinical staff inclusion criteria:
  • Primary care provider (MD/DO, NP), Nurse, Medical Assistant, or administrative staff employed at the participating practices and (b) interacts with at least five patients with a diagnosis of hypertension.

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NYUMC Langone
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.